###begin article-title 0
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1)</italic>
Autosomal dominant optic atrophy (ADOA) is the most common form of hereditary optic neuropathy caused by mutations in the optic atrophy 1 (OPA1) gene. It is characterized by insidious onset with a selective degeneration of retinal ganglion cells, variable loss of visual acuity, temporal optic nerve pallor, tritanopia, and development of central, paracentral, or cecocentral scotomas. Here we describe the clinical and molecular findings in a large Italian family with ADOA.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
Routine ophthalmologic examination and direct sequencing of all coding regions of the OPA1 gene were performed. Further characterization of a new OPA1 gene insertion was performed by reverse transcription-PCR (RT-PCR) of RNA from patients and control subjects.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
We identified an Alu-element insertion located in intron 7 of OPA1 causing an in-frame deletion of exon 8 in 18 family members.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 177 182 <span type="species:ncbi:9606">human</span>
The predicted consequence of this mutation is the loss of the guanosine triphosphatase (GTPase) activity of OPA1. Alu insertions have been reported in the literature as causing human genetic disease. However, this is the first report of a pathogenic OPA1 gene mutation resulting from an Alu insertion.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
Autosomal dominant optic atrophy (ADOA; OMIM ) is the most common form of hereditary optic neuropathy, with an estimated prevalence between 1:10,000 and 1:50,000 in different populations [1]. It is characterized by insidious onset with a selective degeneration of retinal ganglion cells, variable loss of visual acuity, temporal optic nerve pallor, tritanopia, and development of central, paracentral, or cecocentral scotomas [2]. ADOA is inherited in an autosomal dominant manner with high interfamilial and intrafamilial phenotypic variability and incomplete penetrance.
###end p 10
###begin p 11
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1)</italic>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 797 798 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1122 1126 1122 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plus</italic>
###xml 1139 1140 1139 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
Mutations in the optic atrophy 1 (OPA1) gene (that consists of 30 coding exons) are responsible for approximately 90% of cases. OPA1 encodes a large guanosine triphosphatase (GTPase), implicated in the formation and maintenance of the mitochondrial network [3] and in protection against apoptosis by segregating cytochrome c inside the mitochondrial cristae [4]. OPA1 comprises a highly basic N-terminus, a dynamin GTPase domain, and a C-terminus. More than 200 pathogenic mutations have been reported in the literature (see the ). No significant correlation has been observed between degree of visual impairment and location or type of mutation [5]. Missense mutations in OPA1, however, leading to multiple mitochondrial DNA (mtDNA) deletions in skeletal muscle and a mosaic defect of cytochrome c oxidase, were recently found. In these cases the disorder presented with visual failure and optic atrophy in childhood, followed by Progressive External Ophthalmoplegia (PEO), ataxia, deafness, and sensory-motor neuropathy in adulthood. Moreover, some cases show additional neurologic symptoms, the so-called optic atrophy plus phenotypes [6].
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Family study
###end title 13
###begin p 14
###xml 418 426 418 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 800 808 <span type="species:ncbi:9606">patients</span>
Twenty-eight individuals of a single large Italian family were recruited from the Department of Neurologic, Neurosurgical and Behavioral Sciences of Siena, the Italian Union of the Blind of Siracusa and the Department of Pediatric of Catania. There were 15 females and 13 males ranging in age from 9 to 59 years. We use the term "family" to indicate descendants of a multigenerational pedigree of related individuals (Figure 1). Autosomal dominant inheritance was indicated by multiple affected individuals in each generation. All patients underwent routine ophthalmologic examination, including visual acuity, color vision, manual visual field, slit-lamp examination, intraocular pressure (IOP), and dilated fundoscopy. Clinical neurologic examination and genetic analysis was also performed in all patients.
###end p 14
###begin p 15
###xml 170 178 <span type="species:ncbi:9606">patients</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
Pedigree diagram of the Autosomal Dominant Optic Atrophy (ADOA) family. The pedigree of a five-generation family shows eighteen affected members. Solid squares mean male patients, open circles mean normal females, solid circles mean female patients, open squares mean normal males, arrow means proband (V-3). Oblique lines through circles and squares represent deceased, vertical lines indicate the presence of the mutation in two unaffected family members (IV-7 and IV-10) and in another family member not available for ophthalmological examination (V-15).
###end p 15
###begin title 16
Mutation analysis
###end title 16
###begin p 17
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 650 651 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
After informed consent was obtained, 5 ml of blood from the proband, his family members, and healthy controls, was drawn into an ethylenediamine tetraacetic acid (EDTA) sample tube and preserved (frozen). Genomic DNA was extracted from blood samples using a QIAamp DNA blood kit (Qiagen, Limburg, Netherlands). All 30 coding exons (comprising intron-exon boundaries) were amplified by PCR using primers specific for OPA1 (Table 1). PCR reactions were performed in 25 mul reaction volumes containing 100 ng genomic DNA, 10 pmol forward and reverse primers, 100 mM dNTPs, 1U DNA polymerase (Eurotaq DNA polymerase; Euroclone, Milan, Italy), 1.5 mM MgSO4, 1x Reaction buffer, using a DNA thermal cycler (PTC-200; MJ Research, Waltham, MA). The PCR products of exon 8 were cloned into a PCR Cloning Vector pSC-A using the Strata Clonetrade mark PCR Cloning Kit (Agilent Technologies, Stratagene Products Division, Santa Clara, CA). After purification of PCR products with QIAquick PCR Purification kits (Qiagen), sequencing was performed using the automated sequencer ABI 3730 (Applied Biosystems, Foster City, CA).
###end p 17
###begin title 18
DNA sequence of oligonucleotides used for polymerase chain reaction (PCR).
###end title 18
###begin title 19
Reverse Transcriptase-PCR analysis
###end title 19
###begin p 20
###xml 135 143 135 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 174 182 174 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
Peripheral blood, about 10 ml, was collected using vacutainer EDTA tubes (Becton-Dickinson, Franklin Lakes, NJ) from the proband (V-3, Figure 1), the proband's mother (IV-8, Figure 1) and three healthy controls. Total RNA was extracted from peripheral blood leucocytes using the LeukoLOCKtrade mark Total RNA Isolation System following the instruction supplied by the manufacturer (Ambion, Austin, TX). The amount of total RNA extracted from each blood sample was quantified using the NanoDrop ND-1000 photometer (NanoDrop Technologies, Wilmington, DE). For each sample, 1.0 mug of total RNA was reverse transcribed with Affinity Script (Agilent Technologies) using oligo dT primers. PCR amplifications were performed with primers AF1 (5'-GAC CAA CTT CAG GAA GAA CT-3') and AR1 (5'-TGA GGA CCT TCA CTC AGA GT-3'). After the purification of cDNA products with QIAquick PCR Purification kits (Qiagen), sequencing was performed using the automated sequencer ABI 3730.
###end p 20
###begin title 21
Results
###end title 21
###begin title 22
Clinical findings in carriers of mutations
###end title 22
###begin p 23
###xml 41 48 41 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
###xml 439 446 <span type="species:ncbi:9606">patient</span>
Neurologic examination was unremarkable (Table 2). Ophthalmologic examination revealed visual acuity ranging from 20/20 to less than 20/200. Color vision was normal in two subjects, the other 16 had different degrees of color sensitivity deficiency (eight of them showed generalized color sensitivity deficit). IOP with applanation was in the normal range in 11 patients (not exceeding 19-20 mmHg); four subjects had IOP over 20 mmHg. One patient had high IOP (40 mmHg). Optic nerve appearance was normal in two subjects, whereas nine showed temporal pallor and six diffuse neurorim pallor.
###end p 23
###begin title 24
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients clinical findings.
###end title 24
###begin p 25
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
The phenotypic features of seventeen family members with OPA1 mutation are shown. The numbering of patients in the first column is the same as in Figure 1. The second column indicates age at diagnosis (in years). The fourth column indicates results of the Ishihara color test (a test for color blindness). The fifth column indicates intra-ocular pressure with applanation. Abbreviations: C/D represents cup to disk ratio; IOP represents intra-ocular pressure; RE represents right eye; LE represents left eye; N.P. represents not performed; N.A. represents not available.
###end p 25
###begin title 26
Molecular studies
###end title 26
###begin p 27
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 182 193 182 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2, A</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 589 600 589 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B,C</xref>
###xml 606 615 606 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 769 777 769 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 1056 1067 1056 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2D,E</xref>
We sequenced the 30 coding exons of OPA1 in the propositus. We did not find any known pathogenic mutation, but amplification of exon 8 revealed a hemizygous product of about 604 bp (Figure 2, A). Cloning and sequencing of the longer band revealed an insertion of about 325 bp. Using  and  [7] to elucidate the nature of the inserted fragment, we identified 289 bp of the insert as belonging to AluYb8 (99.65% homology with Alu Sb2). The Alu insert was composed of a 289-bp fragment and contained a 25-bp poly(A) tail at its 3' end with perfect direct repeats of 17 bp flanking the insert (Figure 2B,C). In Figure 2C RNA polymerase III promoter (A and B boxes) and the consensus target site sequence are also indicated. The same mutation was found in 17 family members (Figure 1); in ten subjects the mutation was absent, and the analysis was not performed in the remaining family members. The Alu insertion was located in intron 7 of OPA1, 21 bp upstream of exon 8, near the acceptor site (C.784-21_22). The mutation caused the skipping of exon 8 in mRNA (Figure 2D,E).
###end p 27
###begin p 28
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 69 70 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 255 256 255 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 576 577 576 577 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 1012 1013 1012 1013 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1100 1104 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 1182 1183 1182 1183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 163 170 <span type="species:ncbi:9606">patient</span>
###xml 230 237 <span type="species:ncbi:9606">patient</span>
###xml 1121 1128 <span type="species:ncbi:9606">patient</span>
OPA1 mutation in the Autosomal Dominant Optic Atrophy (ADOA) family. A shows the agarose gel of products from polymerase chain reaction (PCR) of exon 8. Lane 1 is patient sample (V-3), lanes 2 and 3 are normal controls, lane 4 is patient's mother (IV-8). B shows comparison of sequences of allele with Alu insertion and normal allele. Exon sequence is shown in bold and highlighted in sky blue; direct repeats flanking the Alu insertion are shown in bold and underlined; Alu element with poly(A) tail is highlighted in yellow; arrows in the normal sequence indicate the cuts. C shows complementary and reverse sequence of mutated region in OPA1 gene with sequence elements of the Alu repeat. Consensus target site is shown in red bold characters and underlined; target-site duplications of the OPA1 gene sequence flanking the integrated DNA are highlighted in sky blue; A and B box sequences (RNA polymerase III promoter) are highlighted in green and violet, respectively; poly(A) tail is highlighted in yellow. D shows the agarose gel of products from reverse transcription-PCR of exons 6-10 of the OPA1 gene. Lane 1 is patient sample (V-3), lanes 2, 3, and 4 are normal controls. E shows electropherogram section with the skipping of exon 8.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
In the case reported here, we found an unusual molecular defect in OPA1 causing ADOA in a large Italian family. The defect is the result of an Alu element insertion.
###end p 30
###begin p 31
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 413 418 <span type="species:ncbi:9606">human</span>
###xml 589 594 <span type="species:ncbi:9606">human</span>
Alu sequences are the most frequent, short, interspersed elements in the human genome, numbering 1.1 million copies and more than 10% of the mass of the genome. Alu elements are sequences of approximately 300 nucleotides flanked by perfect direct repeats of the host sequence, consistent with insertion into staggered nicks in the target DNA [8]. Alu and other repetitive elements have had great influence on the human genome and its evolution [9]. They influence mRNA splicing, RNA editing, and protein translation [10]. Not surprisingly, Alu insertions have been associated with several human genetic disorders. A total of 26 L1 trans-driven Alu insertions have so far been described as causes of diseases [11].
###end p 31
###begin p 32
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 594 596 594 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F8</italic>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 717 724 717 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF6</italic>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
In our case the Alu element was inserted in the antisense direction with respect to OPA1. Alu element insertions in introns can have strong effects on gene expression, especially when inserted in the antisense direction. Five reports indicate that Alu insertions into intronic sequences in antisense orientation and close to the affected exon (19-50 nucleotides) cause the downstream exon to shift from constitutive splicing to full exon skipping or alternative splicing. Three have been found to cause skipping of downstream exons: one impairs correct recognition of the splice acceptor site (F8 gene) [12], while the other two may affect the branch site that is usually very close to the end of the intron (NF1 and TNFRSF6 genes) [13,14]. The orientation and position of the Alu in the upstream intron was recently studied. Lev-Maor et al. shed light on the positive and negative effects of Alu elements inserted in antisense orientation immediately upstream of the regulated exon [15].
###end p 32
###begin p 33
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF1</italic>
###xml 225 232 225 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF6</italic>
In our case Alu insertion probably interferes with the branch site leading to production of an alternatively spliced mRNA lacking exon 8. Loss of this exon may be similar to that reported for Alu element insertion in NF1 and TNFRSF6 genes.
###end p 33
###begin p 34
###xml 307 309 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 358 360 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
A consensus target site is probably generated in the antisense strand where integration of the retroposon begins: the first 5'-gtAAAA-3' hexanucleotides (3'CAdownward arrowTTTT 5') of the 17-bp target-site duplication flanking the Alu element matches one of the more frequent consensus sequences perfectly [16]. The sense strand is nicked 17 bp from gtAAAA [17].
###end p 34
###begin p 35
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
Phenotypic expression of this new mutation did not show particular peculiarities since ophthalmologic variability observed in our patients has also been described in other common OPA1 mutations. Moreover, the presence of the mutation in two unaffected family members suggests incomplete penetrance, as previously reported for other OPA1 gene mutations [18].
###end p 35
###begin p 36
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 272 277 <span type="species:ncbi:9606">human</span>
In conclusion, we describe an AluYb8 [8] retrotransposition event in an intron of the OPA1 gene leading to exon skipping. The predicted consequence of this mutation is the loss of the GTPase activity of OPA1. Alu insertions have been reported in the literature as causing human genetic disease. However, this is the first report of a pathogenic OPA1 gene mutation resulting from an Alu insertion.
###end p 36
###begin title 37
Acknowledgments
###end title 37
###begin p 38
###xml 97 105 <span type="species:ncbi:9606">patients</span>
We thank Professor Jerzy Jurka for helpful suggestions on retroposon integration mechanisms, all patients, and Dr. Anna Rubegni for helping with the preparation of this manuscript. This work was supported by a grant from Regione Toscana and Monte dei Paschi Foundation to AF.
###end p 38
###begin title 39
References
###end title 39
###begin article-title 40
Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects.
###end article-title 40
###begin article-title 41
Mitochondrial dysfunction as a cause of optic neuropathies.
###end article-title 41
###begin article-title 42
OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
###end article-title 42
###begin article-title 43
OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.
###end article-title 43
###begin article-title 44
Dominant optic atrophy: correlation between clinical and molecular genetic studies.
###end article-title 44
###begin article-title 45
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
###end article-title 45
###begin article-title 46
Repbase Update, a database of eukaryotic repetitive elements.
###end article-title 46
###begin article-title 47
Alu sequences.
###end article-title 47
###begin article-title 48
Mobile elements: drivers of genome evolution.
###end article-title 48
###begin article-title 49
Alu elements as regulators of gene expression.
###end article-title 49
###begin article-title 50
###xml 91 96 <span type="species:ncbi:9606">human</span>
A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease.
###end article-title 50
###begin article-title 51
Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A.
###end article-title 51
###begin article-title 52
A de novo Alu insertion results in neurofibromatosis type 1.
###end article-title 52
###begin article-title 53
Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.
###end article-title 53
###begin article-title 54
Intronic Alus influence alternative splicing.
###end article-title 54
###begin article-title 55
Whole genome computational comparative genomics: A fruitful approach for ascertaining Alu insertion polymorphisms.
###end article-title 55
###begin article-title 56
Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons.
###end article-title 56
###begin article-title 57
Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.
###end article-title 57

